This provider's $19.0M in total Medicare payments ranks in the 95th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 71% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1036% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $34.24 | $19.49 | 1.76x | $14.75 | $356.4K | 18.2K | 12.9K |
| 2015 | $161.37 | $62.40 | 2.59x | $98.97 | $4.0M | 102.3K | 64.6K |
| 2016 | $279.67 | $138.70 | 2.02x | $140.97 | $6.2M | 31.9K | 26.1K |
| 2017 | $319.64 | $196.60 | 1.63x | $123.04 | $714.9K | 2.9K | 2.8K |
| 2018 | $418.67 | $169.05 | 2.48x | $249.62 | $81.8K | 350 | 204 |
| 2019 | $423.58 | $166.63 | 2.54x | $256.95 | $442.6K | 1.9K | 726 |
| 2020 | $267.10 | $117.75 | 2.27x | $149.35 | $1.9M | 18.8K | 5.2K |
| 2021 | $282.29 | $120.95 | 2.33x | $161.34 | $2.2M | 36.9K | 6.1K |
| 2022 | $259.00 | $112.40 | 2.30x | $146.60 | $2.4M | 48.8K | 6.1K |
| 2023 | $233.33 | $101.34 | 2.30x | $131.99 | $608.6K | 10.4K | 1.8K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 58.1K | $4.7M | $81.24 | 1.48x |
| G0483 | Drug test def 22+ classes | 19.9K | $4.5M | $225.43 | 2.16x |
| 81226 | Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) common variants | 6.0K | $2.6M | $441.75 | 2.39x |
| 81225 | Gene analysis (cytochrome P450, family 2, subfamily C, polypeptide 19) common variants | 6.2K | $1.8M | $285.42 | 2.43x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 35.6K | $882.5K | $24.81 | 1.19x |
| 81241 | Gene analysis (coagulation factor V) Leiden variant | 5.4K | $442.5K | $81.54 | 2.55x |
| G0431 | Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | 4.4K | $386.1K | $88.00 | 1.32x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 15.6K | $360.4K | $23.15 | 1.30x |
| 81291 | Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants | 5.4K | $315.8K | $58.24 | 3.36x |
| 81240 | Gene analysis (prothrombin, coagulation factor II) A variant | 4.6K | $304.3K | $65.66 | 1.93x |
| G0482 | Drug test def 15-21 classes | 1.5K | $270.7K | $178.20 | 2.23x |
| G6046 | Dihydromorphinone | 6.5K | $222.5K | $34.27 | 1.90x |
| 82492 | Chemical analysis | 7.8K | $188.7K | $24.09 | 1.30x |
| 82542 | Chemical analysis using chromatography technique | 7.6K | $183.8K | $24.08 | 1.25x |
| G6045 | Dihydrocodeinone | 6.5K | $178.9K | $27.53 | 2.18x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 6.7K | $173.0K | $25.94 | 1.93x |
| G6052 | Meprobamate | 6.5K | $152.6K | $23.50 | 2.13x |
| 87633 | Detection test for multiple types of respiratory virus | 272 | $152.0K | $558.83 | 1.60x |
| G6053 | Methadone | 6.7K | $145.1K | $21.77 | 2.07x |
| G6042 | Amphetamine or methamphetamine | 5.9K | $121.8K | $20.72 | 2.42x |
This provider submits charges 1.97 times higher than what Medicare actually pays.
A markup ratio of 1.97x means for every $100 Medicare pays, this provider initially charges $197. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data